Rethinking Clinical Trials

OCTOBER 18, 2023

Speaker Keith Marsolo, PhD Associate Professor Department of Population Health Sciences Duke University School of Medicine Slides Keywords PCORnet, Common Data Model, EHR, Social Determinants of Health Key Points There are many different definitions of social determinants of health. It can be complicated to tease out by the insurance name.

Clinical Trials 117

Clinical Trials Clinical Trials Clinical Research Research 117

Pharmaceutical Technology

MAY 1, 2023

CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. In animal models of ovarian cancer, it demonstrated promising results.

Gene Therapy 130

Gene Therapy Gene Development Clinical Trials 130

Drug Discovery World

JANUARY 30, 2024

 She said: “Payment options will be devised to absorb the costs. One  One option is that manufacturers will need to provide a product guarantee or refund the cost in a pay-for-performance model. Reimbursement models: Current healthcare systems may not have appropriate reimbursement models for the one-time, high-cost nature of CGTs.

Gene Therapy 71

Gene Therapy Manufacturing Gene Clinical Trials 71

Drug Discovery World

MAY 22, 2023

But are these price tags a barrier to access? Biotech and pharma are actively working with payers and insurers to deliver on equitable pricing models that ensure access. It is imperative that these payment processes are supported to expand access. million per dose.

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52

XTalks

AUGUST 19, 2022

Register for this free webinar to learn why the agile clinical trial model is a great fit for many rare disease categories, how to navigate the regulatory landscape for agile clinical trials in rare diseases, how to design studies and more. Zynteglo’s hefty price tag of $2.8

Gene Therapy 95

Gene Therapy FDA Approval Gene Clinical Trials 95

Pharma Marketing Network

JUNE 8, 2020

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.

HR 40

HR Marketing Doctors Doctor 40